The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Systematic literature review (SLR) of clinical and real-world observational studies of octreotide LAR for treatment of neuroendocrine tumors (NETs).
 
Rachael Sorg
Consulting or Advisory Role - Abbvie (Inst); Acorda Therapeutics (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bosch Healthcare (Inst); Bristol-Myers Squibb (Inst); Forest Laboratories (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Novartis (Inst)
Research Funding - Abbvie (Inst); Acorda Therapeutics (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bosch Healthcare (Inst); Bristol-Myers Squibb (Inst); Forest Laboratories (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Novartis (Inst); UCB (Inst)
 
Maureen Neary
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Cassie Tang
Consulting or Advisory Role - Abbvie (Inst); Acorda Therapeutics (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Melinta Therapeutics (Inst); Millennium (Inst); Novartis (Inst); Otsuka (Inst); Shire (Inst); UCB (Inst)
Research Funding - Abbvie (Inst); Acorda Therapeutics (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Melinta Therapeutics (Inst); Millennium (Inst); Novartis (Inst); Otsuka (Inst); Shire (Inst); UCB (Inst)
 
Cherry Song
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Millennium (Inst); Novartis (Inst); Otsuka (Inst); Pfizer (Inst); Sanofi (Inst); Shire (Inst); Sunovion (Inst)
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Millennium (Inst); Novartis (Inst); Otsuka (Inst); Pfizer (Inst); Sanofi (Inst); Shire (Inst); Sunovion (Inst)
 
Jipan Xie
Consulting or Advisory Role - Abbvie (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Ethicon (Inst); Forest Laboratories (Inst); Genentech (Inst); Guizhou Baiqiang (Inst); Melinta Therapeutics (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Shire (Inst)
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Ethicon (Inst); Forest Laboratories (Inst); Genentech (Inst); Guizhou Baiqiang (Inst); Melinta Therapeutics (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Shire (Inst)